MacroGenics, Inc. (MGNX) Appoints Atul Saran As Senior Vice President And General Counsel
4/30/2014 9:46:52 AM
ROCKVILLE, Md., April 30, 2014 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq:MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases, today announced that it has appointed Atul Saran as Senior Vice President and General Counsel. Mr. Saran most recently held a leadership role at AstraZeneca as Vice President, Corporate Development and Ventures, and also chaired the MedImmune Ventures Investment Committee.
Help employers find you! Check out all the jobs and post your resume.
comments powered by